Results 161 to 170 of about 12,266 (204)

Intracavernous Injection Therapy as Second-Line Treatment for ED After Radical Prostatectomy: A Literature Review. [PDF]

Medicina (Kaunas)
Vlaicu AG, Mirvald C, Najjar S, Garaz R, Tsaur I, Sinescu I, Surcel C.   +6 more
europepmc   +1 more source

Cyclic nucleotide inactivation in osteoblasts and osteosarcoma cell lines [PDF]

, 2001
Ahlström, Mikael EB
core  

Direct-to-Consumer Erectile Dysfunction Medications: is the Convenience Worth the Cost? [PDF]

Curr Urol Rep
Li MK, Patel DP, Hsieh TC.
europepmc   +1 more source

Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors. [PDF]

Front Pharmacol, 2018
De Toni L, De Rocco Ponce M, Franceschinis E, Dall'Acqua S, Padrini R, Realdon N, Garolla A, Foresta C.   +7 more
europepmc   +1 more source

PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice.

Neural Regen Res, 2017
Wang L, Chopp M, Zhang ZG.
europepmc   +1 more source

Phosphodiesterase-5 Inhibition and Alzheimer's Disease Risk: A Mendelian Randomisation Study. [PDF]

Aging Cell
Alcalde-Herraiz M, Woolf B, Xie J, Anderson E, Gill D, Tzoulaki I, Winchester LM, Yarmolinsky J, Prieto-Alhambra D, Newby D.   +9 more
europepmc   +1 more source

The future of Men’s health with PDE5-inhibitors

Folia Pharmacologica Japonica, 2016
openaire   +3 more sources

Sexual Health After Neurological Disorders: A Comprehensive Umbrella Review of Treatment Evidence. [PDF]

Med Sci (Basel)
Manuli A, Calderone A, Latella D, Quattrini F, Pucciarelli G, Calabrò RS.   +5 more
europepmc   +1 more source

Erectile Dysfunction Drugs as Potential Therapy for Cognitive Decline: Preclinical and Translational Evidence. [PDF]

Cells
Ricciarelli R.
europepmc   +1 more source

PDE5 Inhibitors Do Not Cause NAION

The Journal of Sexual Medicine, 2006
openaire   +1 more source